News stories about Cardinal Health (NYSE:CAH) have been trending somewhat positive this week, Accern reports. Accern scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cardinal Health earned a news impact score of 0.06 on Accern’s scale. Accern also gave media headlines about the company an impact score of 44.5861413436656 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Here are some of the media headlines that may have impacted Accern Sentiment Analysis’s rankings:
- Free Post Earnings Research Report: Cardinal’s Revenue Gained 6%; Adjusted EPS Jumped 13% (finance.yahoo.com)
- One Stock with Higher Beta value: Cardinal Health, Inc. (CAH) – Wallstreet Investorplace (wallstreetinvestorplace.com)
- Cardinal Health (CAH) Up 7.5% Since Earnings Report: Can It Continue? (finance.yahoo.com)
- Cardinal Health, Inc. (NYSE:CAH) – Comprehensive Stock Analysis – Nasdaq Journal (nasdaqjournal.com)
- Cardinal Health, Inc. (CAH) expected to achieve earnings growth of -6.90% for this year – Wallstreet Investorplace (wallstreetinvestorplace.com)
Several equities research analysts have issued reports on CAH shares. Argus downgraded Cardinal Health from a “buy” rating to a “hold” rating in a report on Wednesday, November 15th. Morgan Stanley downgraded Cardinal Health from an “equal weight” rating to an “underweight” rating in a report on Monday, November 20th. Deutsche Bank started coverage on Cardinal Health in a report on Monday, December 4th. They set a “hold” rating and a $64.00 price objective on the stock. ValuEngine downgraded Cardinal Health from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Finally, Evercore ISI started coverage on Cardinal Health in a report on Thursday, January 4th. They set an “in-line” rating and a $67.00 price objective on the stock. Three investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and three have given a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $74.78.
Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, February 8th. The company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.14 by $0.17. The company had revenue of $35.19 billion during the quarter, compared to analyst estimates of $34.63 billion. Cardinal Health had a return on equity of 24.81% and a net margin of 1.37%. The business’s revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.34 EPS. sell-side analysts forecast that Cardinal Health will post 5.42 EPS for the current year.
Cardinal Health declared that its Board of Directors has approved a stock repurchase program on Thursday, February 8th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s management believes its shares are undervalued.
The company also recently announced a quarterly dividend, which will be paid on Sunday, April 15th. Stockholders of record on Monday, April 2nd will be given a $0.4624 dividend. The ex-dividend date is Thursday, March 29th. This represents a $1.85 annualized dividend and a dividend yield of 2.56%. Cardinal Health’s payout ratio is 32.17%.
In other news, insider Patricia Morrison sold 28,532 shares of Cardinal Health stock in a transaction that occurred on Wednesday, February 14th. The stock was sold at an average price of $66.30, for a total value of $1,891,671.60. Following the completion of the transaction, the insider now owns 36,157 shares in the company, valued at approximately $2,397,209.10. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Michael C. Kaufmann sold 18,586 shares of Cardinal Health stock in a transaction that occurred on Monday, January 22nd. The stock was sold at an average price of $73.90, for a total value of $1,373,505.40. Following the completion of the transaction, the chief executive officer now owns 211,849 shares of the company’s stock, valued at approximately $15,655,641.10. The disclosure for this sale can be found here. In the last quarter, insiders sold 55,113 shares of company stock valued at $3,815,073. Insiders own 0.97% of the company’s stock.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.